Evaluation of reactive oxygen metabolites in patients with non-small cell lung cancer after chemotherapy
Conclusions
NSCLC patients had significantly elevated ROMs levels before chemotherapy compared with normal healthy subjects. Chemotherapy may suppress ROMs production in responders but not in non-responders. ROMs level may be a predictor of clinical outcome in patients receiving chemotherapy for NSCLC.
Source: Multidisciplinary Respiratory Medicine - Category: Respiratory Medicine Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Lung Cancer | Non-Small Cell Lung Cancer | Respiratory Medicine | Study